How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients?
Background. Hypertension is considered to be the most common condition in the general population. It is the most important risk factor for premature deaths in the world. Treatment compliance at every stage is a condition for successful antihypertensive therapy, and improving the effectiveness of tre...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | International Journal of Hypertension |
Online Access: | http://dx.doi.org/10.1155/2019/5245184 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832552084663173120 |
---|---|
author | Bartosz Uchmanowicz Anna Chudiak Izabella Uchmanowicz Grzegorz Mazur |
author_facet | Bartosz Uchmanowicz Anna Chudiak Izabella Uchmanowicz Grzegorz Mazur |
author_sort | Bartosz Uchmanowicz |
collection | DOAJ |
description | Background. Hypertension is considered to be the most common condition in the general population. It is the most important risk factor for premature deaths in the world. Treatment compliance at every stage is a condition for successful antihypertensive therapy, and improving the effectiveness of treatment is a major goal in preventing cardiovascular incidents. Treatment noncompliance and lack of cooperation stem from numerous problems of older age, including frailty syndrome. Objective. To evaluate the effect of frailty syndrome on treatment compliance in older patients with hypertension. Methods. The study sample consisted of 160 patients (91 women, 69 men) with hypertension aged 65 to 78 (mean = 72.09, SD = 7.98 years), hospitalized at the University Clinical Hospital due to exacerbation of disease symptoms. Standardised research tools were used: the Tilburg Frailty Indicator questionnaire and the questionnaire for the assessment of treatment compliance in patients with hypertension, the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Results. Frailty syndrome was diagnosed in 65.62% of patients: 35.62% with mild, 29.38% with moderate, and 0.62% with severe frailty. The treatment compliance was 36.14%. The prevalence of the FS and its three components (physical, psychological, social) significantly affected (p <0.05) the global score of the Hill-Bone Compliance to High Blood Pressure Therapy Scale and all subscales: “reduced sodium intake”, “appointment keeping”, and “antihypertensive medication taking”. Conclusions. The coexistence of frailty syndrome has a negative impact on the compliance of older patients with hypertension. Diagnosis of frailty and of the associated difficulties in adhering to treatment may allow for targeting the older patients with a poorer prognosis and at risk of complications from untreated or undertreated hypertension and for planning interventions to improve hypertension control. |
format | Article |
id | doaj-art-73f3b6beb08b4a28bcc99afb7ba01161 |
institution | Kabale University |
issn | 2090-0384 2090-0392 |
language | English |
publishDate | 2019-01-01 |
publisher | Wiley |
record_format | Article |
series | International Journal of Hypertension |
spelling | doaj-art-73f3b6beb08b4a28bcc99afb7ba011612025-02-03T05:59:38ZengWileyInternational Journal of Hypertension2090-03842090-03922019-01-01201910.1155/2019/52451845245184How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients?Bartosz Uchmanowicz0Anna Chudiak1Izabella Uchmanowicz2Grzegorz Mazur3Department of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, 5 Bartla Street, 51-618 Wroclaw, PolandDepartment of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, 5 Bartla Street, 51-618 Wroclaw, PolandDepartment of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, 5 Bartla Street, 51-618 Wroclaw, PolandDepartment and Clinic of Internal and Occupational Diseases and Hypertension, Jan Mikulicz-Radecki University Teaching Hospital in Wroclaw, 213 Borowska Street, 50-556 Wrocław, PolandBackground. Hypertension is considered to be the most common condition in the general population. It is the most important risk factor for premature deaths in the world. Treatment compliance at every stage is a condition for successful antihypertensive therapy, and improving the effectiveness of treatment is a major goal in preventing cardiovascular incidents. Treatment noncompliance and lack of cooperation stem from numerous problems of older age, including frailty syndrome. Objective. To evaluate the effect of frailty syndrome on treatment compliance in older patients with hypertension. Methods. The study sample consisted of 160 patients (91 women, 69 men) with hypertension aged 65 to 78 (mean = 72.09, SD = 7.98 years), hospitalized at the University Clinical Hospital due to exacerbation of disease symptoms. Standardised research tools were used: the Tilburg Frailty Indicator questionnaire and the questionnaire for the assessment of treatment compliance in patients with hypertension, the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Results. Frailty syndrome was diagnosed in 65.62% of patients: 35.62% with mild, 29.38% with moderate, and 0.62% with severe frailty. The treatment compliance was 36.14%. The prevalence of the FS and its three components (physical, psychological, social) significantly affected (p <0.05) the global score of the Hill-Bone Compliance to High Blood Pressure Therapy Scale and all subscales: “reduced sodium intake”, “appointment keeping”, and “antihypertensive medication taking”. Conclusions. The coexistence of frailty syndrome has a negative impact on the compliance of older patients with hypertension. Diagnosis of frailty and of the associated difficulties in adhering to treatment may allow for targeting the older patients with a poorer prognosis and at risk of complications from untreated or undertreated hypertension and for planning interventions to improve hypertension control.http://dx.doi.org/10.1155/2019/5245184 |
spellingShingle | Bartosz Uchmanowicz Anna Chudiak Izabella Uchmanowicz Grzegorz Mazur How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients? International Journal of Hypertension |
title | How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients? |
title_full | How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients? |
title_fullStr | How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients? |
title_full_unstemmed | How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients? |
title_short | How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients? |
title_sort | how may coexisting frailty influence adherence to treatment in elderly hypertensive patients |
url | http://dx.doi.org/10.1155/2019/5245184 |
work_keys_str_mv | AT bartoszuchmanowicz howmaycoexistingfrailtyinfluenceadherencetotreatmentinelderlyhypertensivepatients AT annachudiak howmaycoexistingfrailtyinfluenceadherencetotreatmentinelderlyhypertensivepatients AT izabellauchmanowicz howmaycoexistingfrailtyinfluenceadherencetotreatmentinelderlyhypertensivepatients AT grzegorzmazur howmaycoexistingfrailtyinfluenceadherencetotreatmentinelderlyhypertensivepatients |